T2 Biosystems, Inc. (TTOO) Financials

TTOO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 43.3 million 62.5 million
2023-06-30 37.1 million 73.6 million
2023-03-31 32.7 million 82.6 million
2022-12-31 34.4 million 74.4 million

TTOO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.4 million 877000
2023-06-30 -12.4 million 913000
2023-03-31 -13.1 million 1.8 million
2022-12-31 -10.4 million 1.0 million

TTOO Net Income

No data available :(

TTOO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 24.3 million - 8.6 million
2023-06-30 16.1 million - 8.9 million
2023-03-31 10.1 million - 9.2 million
2022-12-31 10.3 million - 9.6 million

TTOO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.5 million
2023-06-30 809168
2023-03-31 20.3 million
2022-12-31 7.7 million

TTOO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 13000 2.7 million 6.0 million -
2023-06-30 33000 3.9 million 6.3 million -
2023-03-31 120000 4.5 million 7.3 million -
2022-12-31 36000 4.9 million 6.6 million -

TTOO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.5 million 3.9 million
2023-06-30 2.0 million 4.9 million
2023-03-31 2.1 million 4.0 million
2022-12-31 5.5 million 3.8 million

TTOO

Price: $3

52 week price:
2.70
70.00

Payout Ratio Range:
-731.27%
-253.61%

Earnings Per Share: -35.62 USD

P/E Ratio: -0.14

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 168600

Ebitda: -11.7 million

Market Capitalization: 14.0 million

Links: